https://www.selleckchem.com/pr....oducts/amenamevir.ht
Most adverse events were mild or moderate. Limitations Analyses reported require confirmation in larger prospective studies. Conclusions Tapinarof may represent an important advance in the development of topical medicines for treatment of psoriasis.Background Information on risk of depression among among children, adolescents and adults with hidradenitis suppurativa (HS) is limited. Objective To compare risk of new-onset depression in HS patients with that of controls. Methods Retrospective cohort analysis of 49,280 adult and 3,042 p